Viveve Medical, Inc.
Viveve Medical, Inc. (VIVE) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · VIVE · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Viveve Medical, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
VIVE insider buying and selling by quarter
VIVE insider selling · VIVE insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
VIVE executive sell shares · VIVE board member insider trading · VIVE insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Dec 15, 2021 | Basta Steven L Director | Other | 28 | $39 | Form 4 |
| Dec 15, 2021 | Durbin Scott CEO | Other | 2 | $3 | Form 4 |
| Dec 15, 2021 | Robbins Jim B SVP, Finance & Administration | Other | 36 | $51 | Form 4 |
| Jul 1, 2019 | Zaderej Karen L. Director | Award | 37,829 | — | Form 4 |
| Apr 1, 2019 | JORN DEBORA Director | Award | 10,280 | — | Form 4 |
| Apr 1, 2019 | Zaderej Karen L. Director | Award | 14,248 | — | Form 4 |
| Apr 1, 2019 | Zaderej Karen L. Director | Award | 14,248 | — | Form 4 |
| Apr 1, 2019 | Basta Steven L Director | Award | 24,199 | — | Form 4 |
| Jan 29, 2019 | Robbins Jim B VP, Finance & Administration | Award | 27,778 | — | Form 4 |
| Jan 29, 2019 | Durbin Scott CEO · Director | Award | 62,250 | — | Form 4 |
| Jan 29, 2019 | Atkinson James G. CBO & President | Award | 42,420 | — | Form 4 |
| Dec 31, 2018 | JORN DEBORA Director | Award | 10,120 | — | Form 4 |
| Dec 31, 2018 | Zaderej Karen L. Director | Award | 9,524 | — | Form 4 |
| Dec 31, 2018 | JANNEY DANIEL Director | Award | 21,131 | — | Form 4 |
| Oct 1, 2018 | JANNEY DANIEL Director | Award | 8,947 | — | Form 4 |
| Oct 1, 2018 | Zaderej Karen L. Director | Award | 746 | — | Form 4 |
| Oct 1, 2018 | JORN DEBORA Director | Award | 4,285 | — | Form 4 |
| Oct 1, 2018 | Plexico Jon M 10 percent owner | Award | 4,007 | — | Form 4 |
Robbins Jim B
SVP, Finance & Administration
Date
Dec 15
Shares
36
Price
$1.43
Value
$51
Robbins Jim B
VP, Finance & Administration
Date
Jan 29
Shares
27,778
Price
—
Value
—
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About VIVE insider trading
VIVE insider trades
Viveve Medical, Inc. (VIVE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including VIVE. Over the past 12 months, 0 insiders have filed transactions with the SEC. VIVE insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Viveve Medical, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
VIVE insider trading · 5 questionsThe insiders of Viveve Medical, Inc. (VIVE) include executives and directors such as VIVE, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026